13F filer · CIK 2041209
Kedalion Capital Management LLP
LONDON, X0 · filing since Q4 2024 · last filing Nov 6, 2026
Reported value
$4.3B
+$77.9M vs prior
Positions
5
New / sold out
3 / 1
Added / reduced
1 / 1
Turnover
22.0%
buys $934.9M · sells $948.4M
Top-10 weight
100.0%
Biggest buys vs Q2 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | SPDR SERIES TRUST | +9,840,000 | +28.0% | +$883.2M |
| New | ISHARES TRCALL | +500,000 | – | +$51.1M |
| New | WARNER BROS DISCOVERY INC | +16,427 | – | +$508.4K |
| New | ARBUTUS BIOPHARMA CORP | +20,168 | – | +$96.4K |
Biggest sells vs Q2 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | ISHARES TR | -1,232,000 | -82.6% | $-943.5M |
| Sold out | BLOOM ENERGY CORP | -16,000 | -100.0% | $-4.8M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | SPDR SERIES TRUSTST STR P500ETF | 44,970,000 | $4.0B | 94.15% |
| 2 | ISHARES TRCORE S&P500 ETF | 260,000 | $199.1M | 4.64% |
| 3 | ISHARES TRCALLIBOXX INV CP ETF | 500,000 | $51.1M | 1.19% |
| 4 | WARNER BROS DISCOVERY INCCOM SER A | 16,427 | $508.4K | 0.01% |
| 5 | ARBUTUS BIOPHARMA CORPCOM | 20,168 | $96.4K | 0.00% |